Purchase Order 75N92018P00220

This federal contract award, valued at $20,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Genedx, LLC, a wholly owned subsidiary of Opko Health, Inc. The contract provides for the Genedx Hereditary MDS/Leukemia Panel (T830) and Copy Number Variation (CNV) testing services to be made available to potential participants who do not otherwise have access to this genetic testing. The contract is structured as a firm fixed-price purchase order with a period of...

This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Human Genome Research Institute to Genedx, LLC, a subsidiary of Opko Health, Inc. The $25,000.00 firm fixed-price purchase order is for the provision of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing. The contract has a completion date of June 30, 2025. Genedx is the prime...

This is a purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI) to Genedx, LLC, a for-profit limited liability company. The $423,160.00 firm fixed-price contract is for the NHGRI Fellows Training in Clinical Cytogenetics and Biomedical Genome and Genetics program, with a completion date of August 31, 2023. The contract was awarded on August 30, 2018 and does not have a set-aside...

This firm fixed-price contract was awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Genedx, LLC, a provider of genetic testing and diagnostic services. The $5,250 contract tasks Genedx with providing a range of genetic testing services, including mutation analysis, exome and genome sequencing, gene panel testing, and mitochondrial testing, in support of NIH's clinical research missions. This contract is not set aside for any socioeconomic...

This federal contract award is for medical laboratory testing services and was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a leading provider of genetic testing and diagnostic services. The contract, valued at $81,410.00, is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market. Genedx operates from its facilities in Maryland and has held several Indefinite Delivery Vehicle (IDV) contracts with the...

This firm fixed-price purchase order was awarded by the Office of the Chief Operating Officer (a civilian agency), a component of the National Institutes of Health (NIH), to Genedx, LLC, a for-profit limited liability company. The $81,666 contract is for medical laboratory testing services, specifically genetic testing and diagnostic services. Genedx, a wholly owned subsidiary of Opko Health, Inc., provides comprehensive genetic testing, including mutation analysis, exome and genome...

This federal contract award, valued at $89,127.00, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company and provider of genetic testing and diagnostic services. The contract is for medical laboratory testing services, primarily supporting research and clinical programs at the NIH. Genedx holds two significant Indefinite Delivery Vehicle (IDV) contracts with the NIH Clinical Center, one of which was set aside for small...

This federal contract award is for medical laboratory testing services provided by Genedx, LLC to the National Institutes of Health (NIH) Clinical Center. The contract, valued at $100,000.00, is a firm fixed-price purchase order with an ultimate completion date of August 12, 2015. Genedx, a for-profit limited liability company, has been a provider of genetic testing services to the NIH, supporting various research and clinical programs, particularly at the NIH Clinical Center and the National...

This federal contract award, with ID HHSN269201700325PC, was issued by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a for-profit limited liability company. The contract is for $95,385.00 and is for medical laboratory testing services, specifically supporting genetic testing and analysis. The contract is a firm fixed-price purchase order without a set-aside designation, indicating Genedx competed in the open market for this award. Genedx, as a wholly owned subsidiary of...

This federal contract award, valued at $207,840.00, was issued by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Agena Bioscience, Inc., a for-profit corporation that provides genomic testing equipment, reagents, and services. The contract is a firm fixed price purchase order with no set-aside designation. Agena Bioscience has previously received federal contracts from agencies such as the Centers for Disease Control and...